Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Cardiovascular / Cardiology News

NIH Fast Track Grant Awarded To Arteriocyte For Critical Limb Ischemia Research

Main Category: Cardiovascular / Cardiology
Also Included In: Blood / Hematology
Article Date: 23 Sep 2008 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Arteriocyte, a clinical stage biotechnology company announced today the receipt of a fast track Phase I/II Small Business Innovation Research Grant Award (R44HL092706-01) from National Heart, Lung, and Blood Institute (NHLBI), of the National Institutes of Health (NIH). The grant award, is the first installment of the combined $2.5 million grant from the NIH to clinically evaluate the therapeutic feasibility of treating Critical Limb Ischemia with the company's expanded human umbilical cord blood derived stem cell therapy (ALO212) using Arteriocyte's proprietary NANEX cell expansion technology. The company's NANEX technology provides for a rapid ex-vivo culturing of hemangioblasts, an early progenitor cell shown to have potential in improving perfusion in ischemic tissues. The NIH award represents an important step in the company's commercialization of ALO212, its second stem cell pipeline product candidate, transitioning to clinical stage evaluation. The balance of the funding from the NHLBI is expected to be awarded, contingent on successful completion of the Phase I work.

The NANEX technology, developed by Dr. Hai-Quan Mao's research team at Johns Hopkins University, involves electrospun nanofibers that create a synthetic bone marrow "niche" environment, allowing stem cells to rapidly proliferate while maintaining their undifferentiated "stem" property. Arteriocyte is developing the NANEX platform technology for potential therapeutic use in a number of chronic and acute care settings including treatments for Critical Limb Ischemia, Compartment Syndrome, and "Blood Pharming" - the rapid expansion of cells for the commercial manufacture of universal donor blood.

Arteriocyte's research collaborators in the development of this technology include Dr. Christopher Cooper, (The University of Toledo), Drs. Vincent Pompili and Hiranmoy Das (The Ohio State University), Dr. Hai Quan Mao (The Whiting School of Engineering at Johns Hopkins University), and Dr. Amit Patel (University of Utah School of Medicine).

About Arteriocyte

Arteriocyte, a clinical stage Biotechnology Company with facilities in Cleveland, Ohio and Hopkinton, Massachusetts, is developing proprietary stem cell therapies for human clinical applications. Arteriocyte's goal is to develop commercially available stem cell based therapies using multiple sources of adult derived stem cells (marrow, peripheral cord blood, and cartilage). In October of 2007, Arteriocyte partnered with DW Healthcare Partners and Comerica to create Arteriocyte Medical Systems Inc., in order to commercialize and distribute novel medical devices and point of care surgical solutions to improve patient outcomes. Arteriocyte Medical Systems has a strategic partnership with Medtronic that includes Medtronic's cardiac surgery division distributing Arteriocyte Medical System's Magellan™ Autologous platelet and stem cell separation device in the Cardiac Surgery market. The Magellan system is currently in use in over 400 surgical centers worldwide.

http://arteriocyte.com




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
What Is Low Blood Pressure? What Is Hypotension?
03 Aug 2009
Low blood pressure is also known as hypotension. For millions of people who suffer from hypertension (high blood pressure) hypotension may seem great. If symptoms are mild hypotension usually requires no treatment...


Stress and Sports image Stress and Sports

Many people turn to sports to unwind, but the pressure of competition can turn otherwise relaxing pursuits into sources of stress (and affect your game, too). Our panel of experts will discuss what you can do to make sure your sports life helps, rather than hurts, your state of mind...

Life After a Heart Transplant image Life After a Heart Transplant

Heart transplant success is determined by your post-surgery quality of life. Successful patients are able to resume activities they enjoyed before the procedure, such as moderate exercise and sexual activity. Join Dr. Mehmet Oz and ex-baseball star and donor-heart recipient Frank Torre, as they...

View more videos...